Global HLA Typing for Transplant Market Growing at a CAGR of 6.7% | Leading Companies are Thermo Fisher Scientific, Illumina, and Roche

Pune, India, 2020-Jun-02 — /EPR Network/ —

The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the growing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

Market Dynamics

1. Increasing number of transplant procedures
2. Technological advancements in the field of HLA typing
3. Increasing public-private funding for target research activities

The HLA typing for the transplants market, by technology, is segmented into molecular and non-molecular assay technologies. In 2019, the molecular assay technologies  segment accounted for the largest share of the HLA typing for the transplants market. The large share of this segment can be attributed to the benefits offered by  molecular assays such as low turnaround time, high procedural efficacy, the study of multiple samples, and real-time sample analysis.

Based on end-user, the HLA typing for the transplants market is segmented into independent reference laboratories, hospitals & transplant centers, and research  laboratories & academic institutes.

The HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742

Key Questions Addressed by the Report:

1. What are the growth opportunities related to the adoption of HLA typing for transplant products across significant regions in the future?
2. Emerging countries show immense opportunities for the growth and adoption of HLA typing for transplant instruments, related reagents & consumables, and software.
Will this scenario continue in the next five years?
3. Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
4.What are the newest trends and advancements in the HLA typing for the transplants market?

North America accounted for the largest share of the HLA typing for transplants market in 2019
North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic  technologies (includes HLA typing) among medical professionals, the large volume of organ transplantation procedures performed in the region, and technological
advancements in the field of transplant diagnostics are the major factors driving the market in North America.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742

Key Players and Strategies Adopted by Them:

Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), Immucor, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), Omixon (Hungary)